52North - creators of Neutrocheck®

52North is a British technology company that creates the Aster™ platform for multiplexing cell-based and soluble biomarkers from a single sample in a rapid, easy-to-use, and portable format. The company is headquartered in the United Kingdom.

Here are key aspects of the company:

• Products & Services: The company offers the world's first portable platform designed specifically for cell measurement.
• Innovation: Their patented Aster™ technology enables multiplexing across both cell-based and soluble biomarkers from a single sample.
• Operations: The platform is engineered to be rapid, easy-to-use, and portable for diverse applications.

52North distinguishes itself by delivering advanced diagnostic capabilities through its unique, patent-protected portable solution for complex biomarker analysis.